If a patient has non‑patent bronchi due to fibrotic obliteration, how would that present clinically?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clinical Presentation of Non-Patent Bronchi Due to Fibrotic Obliteration

A patient with non-patent bronchi from fibrotic obliteration (constrictive bronchiolitis) presents with progressive dyspnea on exertion, dry cough, and irreversible airflow obstruction, often with early inspiratory crackles on exam and a surprisingly normal or near-normal chest X-ray. 1

Key Clinical Features

Respiratory Symptoms

  • Progressive shortness of breath that worsens over time and limits activities of daily living 2, 3
  • Persistent dry cough that is typically non-productive 3
  • Exercise intolerance with progressive functional decline 3

Physical Examination Findings

  • Early inspiratory crackles are characteristic and help distinguish this from other obstructive diseases 1, 4
  • The chest examination may otherwise be relatively unremarkable given the severity of disease

Pulmonary Function Testing

The hallmark is severe, irreversible obstructive airway disease with:

  • Fixed airflow obstruction that does not respond to bronchodilators 1
  • Decreased diffusion capacity 2
  • Air trapping on lung volumes 1

Radiographic Appearance

Chest X-ray paradox: The chest radiograph is often normal or shows minimal abnormalities despite significant symptoms—this is a critical diagnostic clue 1, 4

High-resolution CT findings are more revealing and show:

  • Mosaic pattern of perfusion (patchy areas of different attenuation) 1, 5
  • Air trapping on expiratory images—this is diagnostic when combined with clinical features 5
  • Bronchiolectasis (dilated small airways) 4
  • Thickened small airway walls 4
  • Ground-glass opacities may be present 3

Clinical Course and Prognosis

The disease follows a progressive, often fatal course with poor responsiveness to therapy 1. The fibrotic process causes dense eosinophilic scarring beneath the respiratory epithelium, resulting in luminal narrowing or complete fibrous obliteration of the small airways 2.

Common Pitfalls

Do not be falsely reassured by a normal chest X-ray—this is typical of constrictive bronchiolitis and should prompt high-resolution CT imaging if clinical suspicion exists 1, 4.

Consider occult infection—patients with features of bronchiolitis obliterans can have coexisting infections that may improve with treatment, particularly in post-transplant settings 2.

Diagnostic Approach in Specific Contexts

When evaluating suspected cases (particularly post-HSCT):

  • Symptomatic patients with persistent PFT decline should undergo bronchoscopy with BAL to evaluate for infection 2
  • Asymptomatic patients with PFT decline and CT suggesting bronchiolitis should still undergo bronchoscopy with BAL, as occult infection can coexist 2
  • Lung biopsy carries a fourfold increased risk of death compared to clinical diagnosis and should be reserved for cases where diagnosis remains uncertain or alternate conditions are suspected 2

The pathologic finding when biopsy is performed shows constrictive bronchiolitis with concentric fibrosis in the bronchiolar submucosal layer and continual external circular scarring, potentially leading to complete obliteration of the airway lumen 4.

References

Research

Obliterative (constrictive) bronchiolitis.

Seminars in respiratory and critical care medicine, 2012

Research

Severe cryptogenic bronchiolitis: Case report.

Respiratory medicine case reports, 2023

Research

Constrictive bronchiolitis obliterans: the fibrotic airway disorder.

Expert review of respiratory medicine, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.